CompletedPhase 2NCT04021121

Adjunctive Linezolid for the Treatment of Tuberculous Meningitis

Studying Tuberculosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, San Francisco
Principal Investigator
Felicia C Chow, MD
University of California, San Francisco
Intervention
LZD(drug)
Enrollment
40 enrolled
Eligibility
18 years · All sexes
Timeline
2021 – 2023

Study locations (1)

Collaborators

MRC/UVRI and LSHTM Uganda Research Unit · London School of Hygiene and Tropical Medicine · Fogarty International Center of the National Institute of Health

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04021121 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis →

← Back to all trials